acrysof iq monofocal (sn60wf)  (Vivity Labs Inc)

Journal: Cureus

Article Title: Comparison of Clinical Outcomes of Implantation of Foldable Hydrophobic Acrylic Intraocular Lens With and Without Heparin Surface Modification in Indian Diabetic Patients

doi: 10.7759/cureus.56855

Figure Lengend Snippet: Intraocular lens characteristics. IOL = intraocular lens; HSM = heparin surface-modified

Article Snippet: Optic material , Hydrophobic acrylic foldable biconvex, monofocal aspheric (-0.20) AcrySof IQ SN60WF (ALCON laboratories) , Hydrophobic acrylic foldable with heparin-coated surface monofocal, aspheric (-0.12) model CT LUCIA 601PY.

Techniques:

Journal: BMC Ophthalmology

Article Title: Optical bench evaluation of the effect of pupil size in new generation monofocal intraocular lenses

doi: 10.1186/s12886-023-02839-y

Figure Lengend Snippet: Intraocular lens models under evaluation

Article Snippet: Alcon Laboratories, Forth Worth TX, USA , AcrySof® IQ Monofocal (SN60WF) , -0.20 μm , < 37 [ ] , 1.77D.

Techniques:

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: The REVIVE Study: Long Term Outcomes of a Novel Non-Diffractive Extended Vision IOL versus Monofocal Control IOL

doi: 10.2147/OPTH.S390380

Figure Lengend Snippet: Demographics

Article Snippet: Seventeen subjects had bilateral implantation of the AcrySof IQ Vivity lens and 15 subjects had bilateral implantation of the AcrySof IQ Monofocal (SN60WF), all of whom were targeted for emmetropia.

Techniques:

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: The REVIVE Study: Long Term Outcomes of a Novel Non-Diffractive Extended Vision IOL versus Monofocal Control IOL

doi: 10.2147/OPTH.S390380

Figure Lengend Snippet: Mean Binocular Visual Acuities

Article Snippet: Seventeen subjects had bilateral implantation of the AcrySof IQ Vivity lens and 15 subjects had bilateral implantation of the AcrySof IQ Monofocal (SN60WF), all of whom were targeted for emmetropia.

Techniques: Standard Deviation

Journal: Clinical Ophthalmology (Auckland, N.Z.)

Article Title: The REVIVE Study: Long Term Outcomes of a Novel Non-Diffractive Extended Vision IOL versus Monofocal Control IOL

doi: 10.2147/OPTH.S390380

Figure Lengend Snippet: Mean binocular defocus curves of patients with bilateral implantation of either AcrySof IQ Vivity or AcrySof IQ Monofocal IOL demonstrating superior intermediate and near vision with the AcrySof IQ Vivity IOL.

Article Snippet: Seventeen subjects had bilateral implantation of the AcrySof IQ Vivity lens and 15 subjects had bilateral implantation of the AcrySof IQ Monofocal (SN60WF), all of whom were targeted for emmetropia.

Techniques:

Journal: Ophthalmology and Therapy

Article Title: Cost-Effectiveness of Presbyopia Correction Among Seven Strategies of Bilateral Cataract Surgery Based on a Prospective Single-Blind Two-Center Trial in China

doi: 10.1007/s40123-022-00562-3

Figure Lengend Snippet: Effectiveness, total costs, average cost-effectiveness ratios, and one-way sensitivity analyses of the seven strategies

Article Snippet: All patients underwent bilateral phacoemulsification and IOL implantation by experienced surgeons (Dr. Qi in center 1, Dr. Zeng in center 2) and were divided into seven strategies depending on patients’ requirements and preferences: (1) monofocal strategy: bilateral monofocal IOLs [AcrySof IQ SN60WF (Alcon Laboratories, Inc., Fort Worth, TX, USA) or Rayner 920H (Rayner Intraocular Lenses Ltd., Hove, East Sussex, UK)] targeting emmetropia; (2) monovision strategy: monofocal IOLs [AcrySof IQ SN60WF or Rayner 920H] targeting emmetropia in the dominant eye and myopia of − 2.00 D in the nondominant eye; (3) diffractive bifocal strategy: bilateral diffractive bifocal IOLs [AcrySof IQ ReSTOR + 3.0 D SN6AD1 (Alcon Laboratories, Inc., Fort Worth, TX, USA)] targeting emmetropia; (4) blended strategy: blended implantation diffractive bifocal IOLs with near additional power of + 2.5 D [AcrySof IQ ReSTOR + 2.5 D SV25T0 (Alcon Laboratories, Inc., Fort Worth, TX, USA)] in the dominant eye and + 3.0 D [SN6AD1] in the nondominant eye all targeting emmetropia; (5) refractive bifocal strategy, bilateral refractive bifocal IOLs [SBL-3 (Lenstec.

Techniques:

Journal: Ophthalmology and Therapy

Article Title: Cost-Effectiveness of Presbyopia Correction Among Seven Strategies of Bilateral Cataract Surgery Based on a Prospective Single-Blind Two-Center Trial in China

doi: 10.1007/s40123-022-00562-3

Figure Lengend Snippet: Cost categories for bilateral cataract surgery in the seven strategies ($/patient)

Article Snippet: All patients underwent bilateral phacoemulsification and IOL implantation by experienced surgeons (Dr. Qi in center 1, Dr. Zeng in center 2) and were divided into seven strategies depending on patients’ requirements and preferences: (1) monofocal strategy: bilateral monofocal IOLs [AcrySof IQ SN60WF (Alcon Laboratories, Inc., Fort Worth, TX, USA) or Rayner 920H (Rayner Intraocular Lenses Ltd., Hove, East Sussex, UK)] targeting emmetropia; (2) monovision strategy: monofocal IOLs [AcrySof IQ SN60WF or Rayner 920H] targeting emmetropia in the dominant eye and myopia of − 2.00 D in the nondominant eye; (3) diffractive bifocal strategy: bilateral diffractive bifocal IOLs [AcrySof IQ ReSTOR + 3.0 D SN6AD1 (Alcon Laboratories, Inc., Fort Worth, TX, USA)] targeting emmetropia; (4) blended strategy: blended implantation diffractive bifocal IOLs with near additional power of + 2.5 D [AcrySof IQ ReSTOR + 2.5 D SV25T0 (Alcon Laboratories, Inc., Fort Worth, TX, USA)] in the dominant eye and + 3.0 D [SN6AD1] in the nondominant eye all targeting emmetropia; (5) refractive bifocal strategy, bilateral refractive bifocal IOLs [SBL-3 (Lenstec.

Techniques: